P&G is looking for solutions that can become ongoing sources of first party shopping data.
AI Driven Bloodless Blood Tests Sean (Shunsuke) Matsuoka, Co-Founder & COO, GPx GPx: https://gpx.ai/
In an aging society, the number of heart failure patients is increasing, making the prevention of readmissions and reduction of medical costs critical issues. Remote monitoring using invasive implantable devices has proven effective in reducing heart failure readmissions, but its use remains limited.
To address this, GPx has developed an algorithm that non-invasively predicts signs of heart failure exacerbation. This algorithm was created using clinical trial data from monitoring 245 heart failure patients over 6 months to a year at eight facilities, including the Mayo Clinic in the U.S. The algorithm links digital biomarker data with vital blood tests (NT-proBNP and creatinine) to achieve high-precision prediction and early medical intervention.
Additionally, with a grant of 1.2 billion yen provided through AMED, we are collaborating with the National Cerebral and Cardiovascular Center (Dr. Chisato Izumi) to conduct a clinical trial involving 400 patients starting April 2025. The trial will be conducted at the National Cerebral and Cardiovascular Center, Kyoto University, Kobe University, and Kochi University.
Furthermore, at this year's MIT Japan Conference, we will unveil a groundbreaking point-of-care (POC) potassium testing device for the first time. At the conference, we aim to explore the feasibility of applying our technology to other conditions (such as kidney failure, pulmonary arterial hypertension, and cardio-oncology) and to assess the potential for providing algorithm-based services for heart failure patients within Japan.
Elbit America, a fast-growing defense company, is seeking technology partnership with startups in digital transformation, sonar / acoustics, HSA/DM, sensors, augmented reality, artificial intelligence / machine learning, optics, non GPS dependent precision north finding & non GPS dependent precision navigation and timing, precision Line of Sight (LOS) sensing, optical communications, and advanced video and image processing.
Marcus Dahllöf - Introductory Remarks
The 2024 MIT Houston Symposium will gain the insights needed to navigate the dramatic changes driven by global economic forces, emerging technologies, and evolving government policies. This event will explore the transformative power of artificial intelligence (AI), essential workforce development strategies, groundbreaking advancements in manufacturing, shifting international trade patterns, and the impact of recent U.S. legislation on industrial policy.
Please visit the MIT ILP site for the full agenda.
Please join us at the annual MIT Research and Development Conference: Innovating at the Inflection Point: Creating a Better World on November 15-16, 2022 to hear from MIT researchers, MIT Startup Exchange entrepreneurs, and global business leaders dedicated to innovating to create a better world.
Marcus Dahllof, Program Director, MIT Startup Exchange, "Connecting industry to startups"
P&G is looking to partner with companies and emerging disruptors to address key shopper and retailer pain points in urban to deliver a breakthrough experience which disproportionately drives P&G brands.